Literature DB >> 7088412

Purine levels in the intact rat brain. Studies with an implanted perfused hollow fibre.

T Zetterström, L Vernet, U Ungerstedt, U Tossman, B Jonzon, B B Fredholm.   

Abstract

A thin dialysis tube was implanted stereotaxically under halothane anesthesia in the caudate nucleus of Sprague-Dawley rats and perfused with Ringer solution at a rate of 2 microliters/min. Initially there was a high rate of purine outflow but after 1-2 h of perfusion the rate was essentially constant (anesthetized - adenosine 0.4 +/- 0.04 microM, inosine 0.8 +/- 0.2 microM; non-anesthetized - adenosine 0.33 +/- 0.03 microM, inosine 0.21 +/- 0.07 microM). Hypoxia (9% O2) increased the levels more than 3-fold. The adenosine deaminase inhibitor erythro-2-(2-hydroxy-3-nonyl)adenine (EHNA) increased the adenosine level and decreased the inosine level. In vitro recovery of adenosine was about 30%. Therefore, we conclude that the free exchangable concentration of adenosine in the rat brain is likely to be 102 micro M. This level is high enough to potentially affect central nervous function.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7088412     DOI: 10.1016/0304-3940(82)90338-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  61 in total

1.  Characterization of inhibition mediated by adenosine in the hippocampus of the rat in vitro.

Authors:  U Gerber; R W Greene; H L Haas; D R Stevens
Journal:  J Physiol       Date:  1989-10       Impact factor: 5.182

2.  Effects of an inhibitor of adenosine deaminase, deoxycoformycin, and of nucleoside transport, propentofylline, on post-ischemic recovery of adenine nucleotides in rat brain.

Authors:  J W Phillis; M H O'Regan
Journal:  Neurochem Res       Date:  1996-03       Impact factor: 3.996

3.  Differential post-mortem release of noradrenaline and dopamine: a re-evaluation.

Authors:  Z L Rossetti; G L Gessa
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Adenosine deaminase and adenosine uptake inhibitions facilitate ventilation in rats.

Authors:  E C Monteiro; J A Ribeiro
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-08       Impact factor: 3.000

5.  Neurotransmitter activation of inwardly rectifying potassium current in dissociated hippocampal CA3 neurons: interactions among multiple receptors.

Authors:  D L Sodickson; B P Bean
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

Review 6.  Release and actions of adenosine in the central nervous system.

Authors:  M J Higgins; H Hosseinzadeh; D G MacGregor; H Ogilvy; T W Stone
Journal:  Pharm World Sci       Date:  1994-04-15

7.  Enhanced corneal absorption of erythromycin by modulating P-glycoprotein and MRP mediated efflux with corticosteroids.

Authors:  Sudharshan Hariharan; Sriram Gunda; Gyan P Mishra; Dhananjay Pal; Ashim K Mitra
Journal:  Pharm Res       Date:  2008-10-29       Impact factor: 4.200

Review 8.  Adenosine receptors as drug targets--what are the challenges?

Authors:  Jiang-Fan Chen; Holger K Eltzschig; Bertil B Fredholm
Journal:  Nat Rev Drug Discov       Date:  2013-04       Impact factor: 84.694

9.  Action of adenosine receptor antagonists on hypoxia-induced effects in the rat hippocampus in vitro.

Authors:  M D Croning; T S Zetterström; D G Grahame-Smith; N R Newberry
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

10.  Release of endogenous adenosine and its metabolites by the activation of NMDA receptors in the rat hippocampus in vivo.

Authors:  Y Chen; D I Graham; T W Stone
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.